Russia claims to be first country to develop Covid vaccine for animals in mutation fight

France 'far ahead' on vaccines by end of semester says Castex

When you subscribe we will use the information you provide to send you these newsletters.Sometimes they’ll include recommendations for other related newsletters or services we offer.Our Privacy Notice explains more about how we use your data, and your rights.You can unsubscribe at any time.

The jab, named Carnivak-Cov, will help contain transmission of new Covid-19 variants, according to the Russian agriculture supervision entity Rosselkhoznadzor. It will enter the mass production stage this month after being tested on cats, dogs, mink and foxes.

The vaccine has been formulated for use on pets and some farm animals and will be available for purchase to foreign customers, according to reports.

Rosselkhoznadzor said buyers from Canada, the US, Singapore and Poland have shown interest in purchasing the jab.

Konstantin Savenkov, deputy head of the agency, said: “All test animals that were vaccinated developed antibodies to coronavirus in 100 percent of cases.

“It is the world’s first and only product for preventing Covid-19 in animals.”

Mr Savenkov said all the inoculated animals developed antibodies and that the findings of the study gave Russia “grounds to conclude that the vaccine is safe and has strong immunogenic effect.”

According to the official, the study found that the effect of the jab “is estimated to last no less than six months.”

He added: “According to Russian scientists, the use of the vaccine can prevent further mutations of the virus.”

The breakthrough comes as vaccine trials showed the Pfizer jab to be “100 percent effective” in children aged 12 to 13 who received it.

Research conducted in the United States suggested that the Pfizer vaccine is “100 percent effective and well-tolerated” in children aged 12 to 15.

Professor David Salisbury, the Department of Health’s director of immunisation until 2013, hailed the findings from the trial as an encouraging development.

He told Channel 4 News’ Matt Frei: “We do seem to have got data that says that the vaccine is both safe and effective in 12 to 15-year-olds.

Boris warns UK will set fishing limits unless EU budges [INSIGHT]
Germany fines and deports 3 British electricians [DETAILS]
Brexit LIVE: Rejoiners hopes dashed! New poll shows support Brexit [BLOG]

“Which I think is a good step forward.”

The expert added: “What you have to do with a vaccine when you’ve got recommendations for its use in adults is to progressively go down in the ages of children.

“So you do teenagers then you down to below teenagers and you work your way down progressively demonstrating that the vaccine is safe, demonstrating that is is effective until you get to the youngest age group and then you have a recommendation for all ages.”

Source: Read Full Article